King Pharmaceuticals files patent infringement suit against Mutual over generic version of Skelaxin®
Clients King Pharmaceuticals, Inc.
Jones Day represented King Pharmaceuticals in a Hatch-Waxman patent infringement action against Mutual Pharmaceutical Co. Inc. concerning several patents related to Skelaxin®, which is used in the treatment of musculoskeletal disorders.
King Pharmaceuticals, Inc. v. Mutual Pharmaceuticals Co., Inc. (E.D. Pa. 2004)